CORC

浏览/检索结果: 共4条,第1-4条 帮助

已选(0)清除 条数/页:   排序方式:
Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development 期刊论文
ONCOTARGET, 2018, 卷号: 9, 期号: 3
作者:  Grau, Michael;  Gu, Juan J.;  Singh, Anil;  Xue, Kai;  Mavis, Cory
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Early relapse in a case of primary bone marrow diffuse large B-cell lymphoma treated with rituximab-CHOP 期刊论文
IMMUNOTHERAPY, 2017, 卷号: 9, 期号: 5
作者:  Wang, Wanning;  Zhou, Guang-yu;  Zhang, Wenlong
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Early relapse in a case of primary bone marrow diffuse large B-cell lymphoma treated with rituximab-CHOP 期刊论文
IMMUNOTHERAPY, 2017, 卷号: 9, 期号: 5
作者:  Zhang, Wenlong;  Wang, Wanning;  Zhou, Guang-yu
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization 期刊论文
ONCOIMMUNOLOGY, 2016, 卷号: 5, 期号: 5
作者:  Zhang, Fan;  Yang, Junlan;  Li, Huafei;  Liu, Moyan;  Zhang, Jie
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/06


©版权所有 ©2017 CSpace - Powered by CSpace